Valuation: Convatec Group PLC

Market Cap 5.83B 5.09B 4.68B 4.36B 8.27B 555B 8.4B 56.18B 21.84B 273B 21.87B 21.4B 940B P/E 2026 *
21.1x
P/E 2027 * 16.5x
Enterprise Value 7.03B 6.14B 5.64B 5.26B 9.98B 669B 10.13B 67.76B 26.34B 329B 26.37B 25.8B 1,133B EV / Sales 2026 *
2.74x
EV / Sales 2027 * 2.51x
Free-Float
95.19%
Yield 2026 *
2.63%
Yield 2027 * 2.95%
1 day+1.56%
1 week+4.66%
Current month+3.36%
1 month+6.27%
3 months+0.09%
6 months-10.15%
Current year-10.56%
1 week 11.31
Extreme 11.31
11.94
1 month 10.63
Extreme 10.6268
11.94
Current year 10.45
Extreme 10.45
14.09
1 year 10.45
Extreme 10.45
14.95
3 years 9.9
Extreme 9.9
16.65
5 years 8.69
Extreme 8.69
16.65
10 years 0
Extreme 0
18.52
Manager TitleAgeSince
Chief Executive Officer 62 2025-08-03
Director of Finance/CFO 51 2025-08-03
Chief Operating Officer - 2026-05-31
Director TitleAgeSince
Director/Board Member 71 2017-08-13
Chairman 78 2019-09-29
Director/Board Member 62 2020-03-01
Change 5-day change 1-year change 3-year change Capi.($)
+1.56%+4.66% - - 5.83B
+3.49%+1.36%-29.04%-11.15% 166B
+5.04%+2.73%-5.88%-4.24% 106B
+2.80%+3.63%+0.09%+55.53% 57.69B
-1.00%-0.52%+55.15%+57.78% 53.78B
+3.39%+1.39%-10.26%-39.27% 43.56B
+3.50%+11.11% - - 36.52B
+3.47%+1.58%-14.08%-44.37% 27.49B
+0.20%+4.24%+64.56%-2.99% 25.84B
+2.78%+1.17%-8.15%-0.33% 21.27B
Average +2.52%+4.67%+6.55%+1.37% 59.87B
Weighted average by Cap. +3.06%+3.80%-3.62%+1.98%

Financials

2026 *2027 *
Net sales 2.57B 2.24B 2.06B 1.92B 3.65B 244B 3.7B 24.75B 9.62B 120B 9.63B 9.43B 414B 2.74B 2.39B 2.2B 2.05B 3.89B 261B 3.95B 26.4B 10.26B 128B 10.28B 10.06B 442B
Net income 276M 242M 222M 207M 392M 26.31B 398M 2.67B 1.04B 12.93B 1.04B 1.01B 44.56B 359M 314M 289M 269M 510M 34.22B 518M 3.47B 1.35B 16.82B 1.35B 1.32B 57.97B
Net Debt 1.2B 1.05B 964M 898M 1.7B 114B 1.73B 11.57B 4.5B 56.15B 4.5B 4.41B 193B 1.03B 904M 831M 774M 1.47B 98.45B 1.49B 9.97B 3.88B 48.39B 3.88B 3.8B 167B
Logo Convatec Group PLC
ConvaTec Group Plc specializes in the development, manufacturing and marketing of medical devices and products for ostomy care, wound care, and incontinence. The group also offers perfusion devices. Net sales break down by area of activity as follows: - wound care (30.9%): antimicrobial dressings, occlusive dressings, compression bandages, etc.; - ostomy care (27.7%): skin barriers, one-piece bags, 2-piece appliance bags, urostomy bags, etc.; - incontinence care (22%); - infusion (19.4%). At the end of 2025, the group operated 7 production sites worldwide. Net sales are distributed geographically as follows: Europe (29.6%), North Americas (55.7%) and other (14.7%).
Employees
10,910
Date Price Change Volume
26-07-02 US$11.69 +1.56% 17,898
26-07-01 US$11.51 +1.77% 41,573
26-06-30 US$11.31 -0.26% 31,067
26-06-29 US$11.34 +1.52% 17,389
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
2.981USD
Average target price
3.984USD
Spread / Average Target
+33.66%

Quarterly revenue - Rate of surprise